Aspirin use on the rise
Compared to the 1999 data, prevalence of aspirin use in 2003 was up by 20 percent overall, 12 percent for people with cardiovascular disease and 36 percent for those with diabetes.
“The implication is that doctors and the media and paid advertising by (aspirin manufacturers) have had a positive impact."
Aspirin therapy provides significant protection against cardiovascular events, but it works in different ways depending upon gender. Aspirin protects women against ischemic strokes, but not myocardial infarction (MI) or death, while it affords men protection against MI, but not strokes or cardiovascular mortality, according to a new study. This study involved meta-analysis so the results should be cautiously interpreted as the analyzed studies were not uniform.
Does your aspirin work? A new study indicates that, for some individuals, it may not. Researchers discovered that many patients who are prescribed low-dose (75 mg) enteric-coated aspirin for secondary prevention of cardiovascular events have persistent clotting activity. Younger and heavier patients and those with a previous heart attacks are most likely to have an inadequate response to treatment. When given a higher dose, they all responded appropriately. Discuss the dosage with your physician. If there ever was a wonder drug, this is it.